Cardiff Oncology Inc. buy krebskrebs
Start price
16.10.23
/
50%
€1.08
Target price
16.10.24
€1.60
Performance (%)
135.62%
End price
17.10.24
€2.54
Summary
This prediction ended on 17.10.24 with a price of €2.54. The BUY prediction by krebskrebs for Cardiff Oncology Inc. saw massive gains of 135.62%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cardiff Oncology Inc. | -3.252% | -3.252% | -77.860% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by krebskrebs for this prediction
In the thread Trovagene diskutieren
In the thread Trading Trovagene
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten